Matches in Wikidata for { <http://www.wikidata.org/entity/Q82931090> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- Q82931090 description "article scientifique publié en 2006" @default.
- Q82931090 description "artikull shkencor i botuar më 01 janar 2006" @default.
- Q82931090 description "artículu científicu espublizáu en xineru de 2006" @default.
- Q82931090 description "scientific article published on 01 January 2006" @default.
- Q82931090 description "wetenschappelijk artikel" @default.
- Q82931090 description "наукова стаття, опублікована в січні 2006" @default.
- Q82931090 name "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 name "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 name "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 type Item @default.
- Q82931090 label "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 label "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 label "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 prefLabel "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 prefLabel "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 prefLabel "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 P1433 Q82931090-66588997-05E6-4782-8313-F6D5B77A1523 @default.
- Q82931090 P1476 Q82931090-2209A33E-C7F6-4A02-8214-978D184164C5 @default.
- Q82931090 P2093 Q82931090-10D7E518-B72E-4A7C-8092-9741C8266D50 @default.
- Q82931090 P2093 Q82931090-21D348DA-A030-4399-B7FF-8B5F4AF79DEC @default.
- Q82931090 P2093 Q82931090-50A1F206-7C69-4888-A733-E6614AE4C6C4 @default.
- Q82931090 P2093 Q82931090-5C778489-B488-4AF8-9B25-60EBA85E03DD @default.
- Q82931090 P2093 Q82931090-646F0480-348C-4DE6-A827-B7F8F88913D5 @default.
- Q82931090 P2093 Q82931090-711AA516-7300-4C05-B6A1-869756147EAC @default.
- Q82931090 P2093 Q82931090-81653204-6CC0-4A82-AFA2-276C9434230F @default.
- Q82931090 P2093 Q82931090-AB1624E9-3B49-4D6C-B69E-BA8F26DF154B @default.
- Q82931090 P2093 Q82931090-DDFE9FC7-050D-472F-9232-B0D86EEB2192 @default.
- Q82931090 P2093 Q82931090-F63CB2FA-AD59-45A1-8E5B-D4191B59A98E @default.
- Q82931090 P2860 Q82931090-0862669A-F6A5-47AB-B359-4764B423AE6D @default.
- Q82931090 P2860 Q82931090-0F7393C6-2276-4981-B96E-ADBD38B63127 @default.
- Q82931090 P2860 Q82931090-225E3EFE-8FAB-4862-8E79-404EDD20FA87 @default.
- Q82931090 P2860 Q82931090-24057B48-320C-465F-B525-BDD52BB38E22 @default.
- Q82931090 P2860 Q82931090-35AED670-4918-4739-B2F6-C37D2393821D @default.
- Q82931090 P2860 Q82931090-4A79F431-BF8F-465E-AEB9-272865CA7315 @default.
- Q82931090 P2860 Q82931090-56ED647C-84EF-4395-ABF6-CE5C192DC2DA @default.
- Q82931090 P2860 Q82931090-619C5BC4-7062-473C-9CC3-1E856FDFB542 @default.
- Q82931090 P2860 Q82931090-A23B731D-871C-4D3E-B7A1-D3B4874C5235 @default.
- Q82931090 P2860 Q82931090-B0271644-44A3-417C-9FC0-02014B169C65 @default.
- Q82931090 P2860 Q82931090-B187155A-7331-4137-AD44-B24A1AA0D9CF @default.
- Q82931090 P2860 Q82931090-B68DB6C0-1527-4585-AE5F-35FF8AC7BEE4 @default.
- Q82931090 P2860 Q82931090-E8F2D503-3951-4F25-9E5E-7DCD13C397F2 @default.
- Q82931090 P2860 Q82931090-F623ECC7-5FF1-4037-930D-C28A49F2BDB9 @default.
- Q82931090 P2888 Q82931090-15439754-1A6C-4603-95AD-165F9A2A12F0 @default.
- Q82931090 P304 Q82931090-901E796C-0E83-4A2B-BEC2-C43206D439AC @default.
- Q82931090 P31 Q82931090-DC510F80-B760-42C1-B026-E23042366ACE @default.
- Q82931090 P356 Q82931090-4208E526-5DF4-4186-9889-DD093478649E @default.
- Q82931090 P433 Q82931090-FA5BD396-76AE-4584-A198-DFD18DEEFA81 @default.
- Q82931090 P478 Q82931090-E45A74B7-5A31-4340-8932-752EFBB65421 @default.
- Q82931090 P50 Q82931090-096677A0-370D-4AAD-ABFD-29B410CA84F7 @default.
- Q82931090 P577 Q82931090-DBB67F2E-E726-4077-83AD-4A3F31EA4B1C @default.
- Q82931090 P6179 Q82931090-5E089769-C09D-424C-AA94-F399AFB8AEA5 @default.
- Q82931090 P698 Q82931090-31937E4F-6A24-4A49-B4CF-E9B96A009E8E @default.
- Q82931090 P921 Q82931090-1551FA61-97AE-4554-B6E2-F7A2131F3DED @default.
- Q82931090 P921 Q82931090-BCAC9655-613D-4BD7-A028-FA9A5CC8EB45 @default.
- Q82931090 P921 Q82931090-FA1F9A60-6BFE-4520-9F8D-736F5AF42AA1 @default.
- Q82931090 P356 S10120-005-0353-4 @default.
- Q82931090 P698 16557433 @default.
- Q82931090 P1433 Q15724608 @default.
- Q82931090 P1476 "Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study" @default.
- Q82931090 P2093 "Aristotelis Bamias" @default.
- Q82931090 P2093 "Athanassios Sakantamis" @default.
- Q82931090 P2093 "Dimitrios Bafaloukos" @default.
- Q82931090 P2093 "Dimitrios Janinis" @default.
- Q82931090 P2093 "Dimitrios Tsavdaridis" @default.
- Q82931090 P2093 "Dimosthenis Skarlos" @default.
- Q82931090 P2093 "George Fountzilas" @default.
- Q82931090 P2093 "Nikos Xiros" @default.
- Q82931090 P2093 "Paris Kosmidis" @default.
- Q82931090 P2093 "Pavlos Papakostas" @default.
- Q82931090 P2860 Q33332444 @default.
- Q82931090 P2860 Q33363249 @default.
- Q82931090 P2860 Q33388301 @default.
- Q82931090 P2860 Q33421327 @default.
- Q82931090 P2860 Q33488159 @default.
- Q82931090 P2860 Q36069967 @default.
- Q82931090 P2860 Q36080032 @default.
- Q82931090 P2860 Q40938936 @default.
- Q82931090 P2860 Q45230546 @default.
- Q82931090 P2860 Q45241257 @default.
- Q82931090 P2860 Q53610419 @default.
- Q82931090 P2860 Q70175918 @default.
- Q82931090 P2860 Q74000577 @default.
- Q82931090 P2860 Q74654940 @default.
- Q82931090 P2888 s10120-005-0353-4 @default.
- Q82931090 P304 "26-31" @default.
- Q82931090 P31 Q13442814 @default.
- Q82931090 P356 "10.1007/S10120-005-0353-4" @default.
- Q82931090 P433 "1" @default.
- Q82931090 P478 "9" @default.
- Q82931090 P50 Q56432806 @default.
- Q82931090 P577 "2006-01-01T00:00:00Z" @default.
- Q82931090 P6179 "1008630241" @default.
- Q82931090 P698 "16557433" @default.
- Q82931090 P921 Q238512 @default.
- Q82931090 P921 Q420436 @default.
- Q82931090 P921 Q974135 @default.